MedPath

A Study of Breath Testing for Small Intestinal Bacterial Overgrowth

Not Applicable
Recruiting
Conditions
Regurgitation
Gastroesophageal Reflux
Heartburn
Interventions
Other: Breath Testing
Registration Number
NCT05976165
Lead Sponsor
Mayo Clinic
Brief Summary

Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Breath Test Evaluation for SIBOBreath TestingSubjects with symptoms of gastroesophageal reflux disease (GERD) treated with a short course of proton pump inhibitors (PPI) clinically will undergo breath testing evaluating for small intestinal bacterial overgrowth (SIBO).
Primary Outcome Measures
NameTimeMethod
Incidence of SIBO after treatment with PPIAfter PPI therapy, approximately 8 weeks

Number of subjects to have a positive breath testing for small intestinal bacterial overgrowth (SIBO) after clinical treatment of proton pump inhibitors (PPI ).

Secondary Outcome Measures
NameTimeMethod
Symptoms of SIBO after treatment with PPIAfter PPI therapy, approximately 8 weeks

Measured using the self-reported Mayo Bloating Questionnaire to assess symptoms of bloating and abdominal distension. Comprised of 45 questions addressing symptoms of bloating/distention. Other questionnaires include a diarrhea survey and the GERDQ.

Symptoms of SIBO before treatment with a PPIBaseline

Measured using the self-reported Mayo Bloating Questionnaire to assess symptoms of bloating and abdominal distension. Comprised of 45 questions addressing symptoms of bloating/distention. Other questionnaires include a diarrhea survey and the GERDQ.

Incidence of SIBO before treatment with a PPIBaseline

Number of subjects to have a positive breath testing for small intestinal bacterial overgrowth (SIBO) before clinical treatment of proton pump inhibitors (PPI ).

Trial Locations

Locations (1)

Mayo Clinic Florida

🇺🇸

Jacksonville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath